Regeneron, US75886F1075

Regeneron stock heads into the open after a 1.5 percent drop

Published on 09/14/2026 at 04:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 11, 2026, Regeneron stock fell 1.5 percent to USD 781.49 on Nasdaq. Trading volume was 443,972 shares, and the next session starts with the Morgan Stanley health care conference on deck.

Fotorealistisches Biotech-Labor mit Forschern und Pipetten an sterilen Arbeitsplätzen
Regeneron Pharma US75886F1075 zeigt ein fotorealistisches Biotech-Labor mit Forschern bei sorgfältigen Pipettierarbeiten am sterilen Steriltisch, Illustration mit AI erstellt.

Regeneron stock closed at USD 781.49 on Nasdaq on September 11, 2026, down 1.5 percent. The move came as the S&P 500 finished the session at 7,655.67, leaving the shares weaker than the broader market.

September 11, 2026 in numbers

Regeneron Pharmaceuticals Inc. (ISIN US75886F1075, Nasdaq: REGN) traded between USD 780.81 and USD 800.22, with volume of 443,972 shares. The close sat 8.9 percent below the 52-week high of USD 859.34 and 44.4 percent above the 52-week low of USD 541.00.

MarketBeat showed the next item on the company calendar as the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026, a setting that can keep investor attention on the shares. Yahoo Finance also lists earnings for Regeneron on October 28, 2026.

Conference day today

Regeneron appears on the Morgan Stanley 24th Annual Global Healthcare Conference calendar today, according to MarketBeat. Yahoo Finance also shows the companys next earnings date as October 28, 2026, which keeps the reporting timeline in view for traders before the open.

Disclaimer...

en | US75886F1075 | REGENERON | boerse | 70096260 | bgmi